Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Good
|
|
New words:
agreed, area, Auckland, automation, billion, biochemistry, body, Branch, brand, broadened, clinical, complaint, complementary, consummate, consummated, consummation, contractually, convenient, coupon, dealing, disease, driven, embedded, Eugene, excellence, exceptionally, FASB, fewer, final, focused, footprint, Genicon, goal, governmental, great, Gregory, high, instrument, investigation, issuable, leadership, Lucier, member, modified, move, network, Newcastle, Oregon, Pan, partner, percent, perpetual, preeminent, Priority, protein, proven, purport, ratio, recommending, reinterpreted, reputation, requisite, satisfaction, seasonal, seventy, stringent, stronger, Superfund, team, therapeutic, track, transformed, turnover, understand, unnecessary, unused, Vera, vision, workmen
Filing tables
Filing exhibits
aTyr Pharma similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
I, C. Eric Winzer, Chief Financial Officer of Invitrogen Corporation (the “Registrant”), do hereby certify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:
| (1) the Quarterly Report on Form 10-Q of the Registrant, to which this certification is attached as an exhibit (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and | |||
| (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
| Dated: August 6, 2003 | /s/ C. Eric Winzer C. Eric Winzer Chief Financial Officer |